Park Soon-jae is the CEO of Alteogen.
He aims to grow the company into a global pharmaceutical firm by developing not only biosimilars (biopharmaceutical generics) but also biobetters (improved biopharmaceuticals).
He was born on December 22, 1954, in Gunsan, North Jeolla Province.
He graduated from Seoul High School and earned a bachelor’s degree in biochemistry from Yonsei University. He then received both his master’s and doctoral degrees in chemistry from Purdue University in the United States.
After working as a researcher at the Massachusetts Institute of Technology (MIT), he joined Lucky Biotech Research Institute (now LG Chem Research Institute) as a senior researcher.
He later moved to Hanwha Petrochemical as head of the bio development division, where he led the Dream Pharma project, and subsequently served as CEO of Binex before founding Alteogen in 2008 with his wife, Chung Hye-shin, a professor at Hannam University.
He achieved the milestone of applying a domestically developed platform to the world’s top-selling pharmaceutical product for the first time among Korean biotech companies.
He advocates a management principle that emphasizes possessing a world-first or clearly differentiated platform.
#Alteogen #ParkSoonjae #biobetters #biosimilars #biopharma #Kbio #innovation #PurdueUniversity #MIT #globalpharma